Standard
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men. / May, Margaret; Sterne, Jonathan A C; Shipley, Martin; Brunner, Eric; d'Agostino, Ralph; Whincup, Peter; Ben-Shlomo, Yoav; Carr, Andrew; Ledergerber, Bruno; Lundgren, Jens D; Phillips, Andrew N; Massaro, Joseph; Egger, Matthias.
In:
International Journal of Epidemiology, Vol. 36, No. 6, 2007, p. 1309-1318.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
May, M, Sterne, JAC, Shipley, M, Brunner, E, d'Agostino, R, Whincup, P, Ben-Shlomo, Y, Carr, A, Ledergerber, B
, Lundgren, JD, Phillips, AN, Massaro, J & Egger, M 2007, '
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men',
International Journal of Epidemiology, vol. 36, no. 6, pp. 1309-1318.
https://doi.org/10.1093/ije/dym135APA
May, M., Sterne, J. A. C., Shipley, M., Brunner, E., d'Agostino, R., Whincup, P., Ben-Shlomo, Y., Carr, A., Ledergerber, B.
, Lundgren, J. D., Phillips, A. N., Massaro, J., & Egger, M. (2007).
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men.
International Journal of Epidemiology,
36(6), 1309-1318.
https://doi.org/10.1093/ije/dym135Vancouver
May M, Sterne JAC, Shipley M, Brunner E, d'Agostino R, Whincup P et al.
A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men.
International Journal of Epidemiology. 2007;36(6):1309-1318.
https://doi.org/10.1093/ije/dym135Author
May, Margaret ; Sterne, Jonathan A C ; Shipley, Martin ; Brunner, Eric ; d'Agostino, Ralph ; Whincup, Peter ; Ben-Shlomo, Yoav ; Carr, Andrew ; Ledergerber, Bruno ; Lundgren, Jens D ; Phillips, Andrew N ; Massaro, Joseph ; Egger, Matthias. / A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men. In: International Journal of Epidemiology. 2007 ; Vol. 36, No. 6. pp. 1309-1318.
Bibtex
@article{3d7aeda020ec11ddbc23000ea68e967b,
title = "A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men",
abstract = "Many HIV-infected patients on highly active antiretroviral therapy (HAART) experience metabolic complications including dyslipidaemia and insulin resistance, which may increase their coronary heart disease (CHD) risk. We developed a prognostic model for CHD tailored to the changes in risk factors observed in patients starting HAART.",
keywords = "Adult, Aged, Anti-Retroviral Agents, Antiretroviral Therapy, Highly Active, Coronary Disease, Follow-Up Studies, Great Britain, HIV Infections, HIV-1, Humans, Male, Middle Aged, Prognosis, Proportional Hazards Models, Risk Assessment, Risk Factors",
author = "Margaret May and Sterne, {Jonathan A C} and Martin Shipley and Eric Brunner and Ralph d'Agostino and Peter Whincup and Yoav Ben-Shlomo and Andrew Carr and Bruno Ledergerber and Lundgren, {Jens D} and Phillips, {Andrew N} and Joseph Massaro and Matthias Egger",
year = "2007",
doi = "10.1093/ije/dym135",
language = "English",
volume = "36",
pages = "1309--1318",
journal = "International Journal of Epidemiology",
issn = "0300-5771",
publisher = "Oxford University Press",
number = "6",
}
RIS
TY - JOUR
T1 - A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men
AU - May, Margaret
AU - Sterne, Jonathan A C
AU - Shipley, Martin
AU - Brunner, Eric
AU - d'Agostino, Ralph
AU - Whincup, Peter
AU - Ben-Shlomo, Yoav
AU - Carr, Andrew
AU - Ledergerber, Bruno
AU - Lundgren, Jens D
AU - Phillips, Andrew N
AU - Massaro, Joseph
AU - Egger, Matthias
PY - 2007
Y1 - 2007
N2 - Many HIV-infected patients on highly active antiretroviral therapy (HAART) experience metabolic complications including dyslipidaemia and insulin resistance, which may increase their coronary heart disease (CHD) risk. We developed a prognostic model for CHD tailored to the changes in risk factors observed in patients starting HAART.
AB - Many HIV-infected patients on highly active antiretroviral therapy (HAART) experience metabolic complications including dyslipidaemia and insulin resistance, which may increase their coronary heart disease (CHD) risk. We developed a prognostic model for CHD tailored to the changes in risk factors observed in patients starting HAART.
KW - Adult
KW - Aged
KW - Anti-Retroviral Agents
KW - Antiretroviral Therapy, Highly Active
KW - Coronary Disease
KW - Follow-Up Studies
KW - Great Britain
KW - HIV Infections
KW - HIV-1
KW - Humans
KW - Male
KW - Middle Aged
KW - Prognosis
KW - Proportional Hazards Models
KW - Risk Assessment
KW - Risk Factors
U2 - 10.1093/ije/dym135
DO - 10.1093/ije/dym135
M3 - Journal article
C2 - 17652317
VL - 36
SP - 1309
EP - 1318
JO - International Journal of Epidemiology
JF - International Journal of Epidemiology
SN - 0300-5771
IS - 6
ER -
